about
Recent advances in lymphatic targeted drug delivery system for tumor metastasisDevelopment and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.Antimicrobial photodynamic therapy using a diode laser with a potential new photosensitizer, indocyanine green-loaded nanospheres, may be effective for the clearance of Porphyromonas gingivalis.Advances in lymphatic imaging and drug delivery.Development of individualized anti-metastasis strategies by engineering nanomedicinesChemical modification and formulation approaches to elevated drug transport across cell membranes.Ligand-based targeted therapy for cancer tissue.Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light.A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.Nanopharmaceuticals to target antifilarials: a comprehensive review.Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.Small Wonders-The Use of Nanoparticles for Delivering Antigen.Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1.Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model.Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line.Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticlesEase of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles.Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study.Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model.Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.Fluorescent molecular imaging of metastatic lymph node using near-infrared emitting low molecular weight heparin modified nanoliposome based on enzyme-substrate interaction.Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting.Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting.Lymphatic-targeted therapy following neoadjuvant chemotherapy: a promising strategy for lymph node-positive breast cancer treatment.Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune PotentiationtLyP-1-conjugated mesoporous silica nanoparticles for tumor targeting and penetrating hydrophobic drug deliveryNanoparticle Vaccines Against Infectious DiseasesFactorial Design Studies and Biopharmaceutical Evaluation of Simvastatin Loaded Solid Lipid Nanoparticles for Improving the Oral BioavailabilityLymphatic uptake of lipid nanoparticles following endotracheal administration
P2860
Q27005580-2A974F22-7096-4132-8F3F-55436B90BC39Q33986062-ECE4E9B5-C16D-48F2-8D59-E9A548A29152Q34547496-A17E3242-E122-47CE-AF64-A81E9B1A6A5CQ35188498-8C01AB48-94C5-4AB6-AE15-CCEE8ABDE3A1Q35967474-9EEEC293-8F24-4D3B-BD84-813A0C7936BBQ36527751-FBBAD1A6-BDC8-4C76-92D0-A902C81CA1A8Q37425224-954DBEF0-0838-496C-9FF8-2794149A1297Q37607079-1A6AEC19-94D7-4689-8831-04EAFDBE2A52Q37708403-21418959-3340-4ECF-880D-2492028C2E90Q37798553-AB46C7FE-43FE-4166-A8F6-B6A4FC7CDE2FQ38083301-1578C940-720A-4E87-94B1-5C6E062E9355Q38134133-0F06B890-B191-4F15-8628-192907A9586CQ38151736-A665AA84-338C-47E3-9C48-AFA02F6A38E4Q38172276-945CB999-70E1-46F9-9503-00D82C380383Q38583148-575DB68D-01FB-4FAF-8ABA-707973B30C90Q39151249-6E13C532-03CE-48BF-A00C-30E76AC8C8E2Q39758165-320F063E-040D-47AA-9568-C1FEF97824F0Q40110831-BEC7B3A0-ACDF-4CA3-BBC8-31C9614F91FFQ40452965-B0C46462-B8BE-45E3-94FE-196DB8B0F7FDQ41871280-77E052C4-61B4-4ACF-8599-F9308E55B5CFQ41989956-9A3F22C1-B2F4-460A-8BBF-AAE67E814753Q42740833-9310D0D9-16C0-45BB-8B3F-05C696FD6AC1Q44363688-8576BB15-DFB7-47FE-9716-694D46A0808EQ46432792-7F77AB72-6002-4C13-8942-0AE5A9C13EB0Q46970810-0FF7C834-69C8-418D-BDFE-B8FF46B2C233Q47276591-C1DBB5AD-44E9-42C9-8B01-7235CB4E7D5FQ48376807-EEC47923-D230-4A5C-9778-544165907D82Q50046376-2A005A75-42F3-4B93-AF41-EB3B8E8D24AFQ50196485-06C06CE8-9CBC-4DC0-AEE1-C7C62364AC8CQ50972893-D6788A3D-3973-40D3-A5DC-E7F407B6F1F1Q53528770-4C58CFB9-4F7A-487B-8B66-C3D2538B69B2Q56993652-0630C31E-2EE2-48AC-89DB-03051FAF6DBDQ57348031-EDFC9D38-F342-47E2-8B8B-1FC8F7B37014Q58583890-88C5A16F-2047-40CE-A961-221130CD4993Q59049929-E42B12C9-72B5-4C88-8FA3-583275FF9819Q59166767-F12CDB36-5F8A-449E-8CBC-47A0C2734FBD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lymphatic targeting with nanoparticulate system.
@ast
Lymphatic targeting with nanoparticulate system.
@en
Lymphatic targeting with nanoparticulate system.
@nl
type
label
Lymphatic targeting with nanoparticulate system.
@ast
Lymphatic targeting with nanoparticulate system.
@en
Lymphatic targeting with nanoparticulate system.
@nl
prefLabel
Lymphatic targeting with nanoparticulate system.
@ast
Lymphatic targeting with nanoparticulate system.
@en
Lymphatic targeting with nanoparticulate system.
@nl
P1476
Lymphatic targeting with nanoparticulate system.
@en
P2093
P356
10.1016/S0169-409X(00)00121-6
P407
P577
2001-03-01T00:00:00Z